CVS Health Corporation (CVS) financial statements (2021 and earlier)

Company profile

Business Address ONE CVS DR.
WOONSOCKET, RI 02895
State of Incorp. DE
Fiscal Year End December 31
SIC 5912 - Drug Stores and Proprietary Stores (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8,0567,5278,5258,3226,58141,69243,911
Cash and cash equivalents5,6835,1936,0635,8964,05941,58743,815
Short-term investments2,3732,3342,4622,4262,52210596
Receivables19,61719,78918,17486817,63114,83714,158
Inventory, net of allowances, customer advances and progress billings17,51616,02815,51115,44816,45014,81814,922
Inventory17,51616,02815,51115,44816,45014,81814,922
Other current assets5,1134,8414,6914,5784,581634799
Other undisclosed current assets   18,641   
Total current assets:50,30248,18546,90147,85745,24371,98173,790
Noncurrent Assets
Finance lease, right-of-use asset 560531 
Operating lease, right-of-use asset20,86020,75720,865 
Property, plant and equipment12,04411,65111,48311,34811,34910,41910,249
Long-term investments and receivables17,31417,34216,97316,41015,732  
Long-term investments17,31417,34216,97316,41015,732  
Intangible assets, net (including goodwill)112,870113,203113,648114,222115,20247,38247,542
Goodwill79,74979,54879,48579,07578,67834,21634,220
Intangible assets, net (excluding goodwill)33,12133,65534,16335,14736,52413,16613,322
Restricted cash and investments271270269266   
Other noncurrent assets4,6004,3854,7634,8655,0461,7241,709
Other undisclosed noncurrent assets4,1883,7603,47124,8003,884  
Total noncurrent assets:172,147171,928172,003171,911151,21359,52559,500
TOTAL ASSETS:222,449220,113218,904219,768196,456131,506133,290
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities22,62521,05719,72218,73319,63614,97316,210
Accounts payable10,4929,4429,1608,2908,9258,8138,570
Accrued liabilities12,13311,61510,56210,44310,7116,1607,640
Deferred revenue737276 
Debt5,4046,6736,1596,8981,9852,1393,540
Contract with customer, liability75   
Other undisclosed current liabilities25,20124,74223,41924,92522,38812,34811,743
Total current liabilities:53,30352,54449,37650,63144,00929,46031,493
Noncurrent Liabilities
Long-term debt and lease obligation, including:64,69983,62386,34967,88871,44460,74761,569
Long-term debt, excluding current maturities 64,20666,94167,88871,44460,74761,569
Finance lease, liability781591559 
Operating lease, liability18,92618,82618,849 
Other undisclosed long-term debt and lease obligation44,992      
Liabilities, other than long-term debt9,4569,4579,90310,1562,7804,6774,617
Deferred tax liabilities, net7,540 3,0523,054
Deferred income tax liabilities7,2947,2797,375 
Other liabilities2,1622,1782,5282,6162,7801,6251,563
Other undisclosed noncurrent liabilities30,82111,55611,67731,08719,680  
Total noncurrent liabilities:104,976104,636107,929109,13193,90465,42466,186
Total liabilities:158,279157,180157,305159,762137,91394,88497,679
Stockholders' equity
Stockholders' equity attributable to parent, including:63,86462,61461,28259,68658,22536,61835,607
Common stock17171717171717
Treasury stock, value(28,235)(28,207)(28,257)(28,221)(28,228)(37,702)(37,749)
Additional paid in capital     32,36032,264
Accumulated other comprehensive income1,019950684433102129141
Retained earnings45,10844,01743,13641,85940,91141,84340,965
Other undisclosed stockholders' equity attributable to parent45,95545,83745,70245,59845,423(29)(31)
Stockholders' equity attributable to noncontrolling interest30631931732031844
Total stockholders' equity:64,17062,93361,59960,00658,54336,62235,611
TOTAL LIABILITIES AND EQUITY:222,449220,113218,904219,768196,456131,506133,290

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues66,88964,81063,43161,64654,90947,26946,708
Cost of revenue(55,198)(53,287)(52,057)(50,706)(44,759)(39,941)(39,507)
Cost of goods and services sold (40,437)(38,970)(37,247) (39,941)(39,507)
Gross profit:11,69111,52311,37410,94010,1507,3287,201
Operating expenses(8,654)(8,595)(8,042)(8,250)(8,841)(4,975)(8,788)
Operating income (loss):3,0372,9283,3322,6901,3092,353(1,587)
Nonoperating income (expense)31313121811(1)(3)
Investment income, nonoperating   249   
Other nonoperating income (expense)313131(31)11(1)(3)
Interest and debt expense(734)(826)(772)(782)(733)(674)(689)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes   (187)(485)221214
Income (loss) from continuing operations before income taxes:2,3342,1332,5911,9391021,899(2,065)
Income tax expense(590)(604)(660)(512)(524)(509)(497)
Income (loss) from continuing operations:1,7441,5291,9311,427(422)1,390(2,562)
Loss from discontinued operations      (1)
Other undisclosed income before gain (loss) on sale of properties    1  
Net income (loss):1,7441,5291,9311,427(421)1,390(2,563)
Net income attributable to noncontrolling interest 156   
Other undisclosed net income attributable to parent3   2  
Net income (loss) available to common stockholders, diluted:1,7471,5301,9361,433(419)1,390(2,563)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net income (loss):1,7441,5291,9311,427(421)1,390(2,563)
Other comprehensive income (loss)69266251331(27)(12)(31)
Comprehensive income (loss):1,8131,7952,1821,758(448)1,378(2,594)
Comprehensive income, net of tax, attributable to noncontrolling interest 156   
Other undisclosed comprehensive income (loss), net of tax, attributable to parent3  (12)2  
Comprehensive income (loss), net of tax, attributable to parent:1,8161,7962,1871,752(446)1,378(2,594)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: